SlideShare a Scribd company logo
1 of 3
Download to read offline
44 / Journal of AHIMA January 16
O
Preventing Hospital Acquired
Infections Starts with Data
Collection
By John R. Cange, MSHI
ONE OUT OF 10 US hospital patients contract an infection dur-
ing their hospital stay, resulting in thousands of unnecessary
deaths and billions of dollars in unnecessary costs. Almost all
hospital acquired infections (HAI) are preventable, which is
why the Centers for Medicare and Medicaid Services (CMS) no
longer reimburse hospitals for the costs to treat HAI.1
To prevent a problem, however, requires that you understand
the potential causes of the problem—and this understanding
requires data. A complete understanding requires a complete
dataset. In the case of HAI, the ideal dataset would contain data
concerning every type of HAI from every hospital in every state.
Only some states require HAI data collection on all of the major
types of HAI. Half of states report on some types of HAIs and not
others, while many hospitals do not report on HAIs of any type.
In the near term, there is little chance that all 50 states will start
requiring HAI reporting by imposing new state regulations, but
there is hope. Hospitals could report on HAIs with little effort
or additional cost by including HAI data with the “meaningful
use” EHR Incentive Program data they already provide to CMS
through their electronic health record (EHR) systems.
EHRs are nearly ubiquitous in US hospitals today. Consequent-
ly, some have argued that CMS should mandate HAI reporting of
alltypesbyreimbursinghospitalsfortheirHAIdataaspartoftheir
meaningful use payments or reducing their HAI reimbursement
if the hospital does not comply. This strategy has been proven to
be very effective with CMS’ meaningful use reporting. Ultimately,
this article serves as a call to action to CMS and an invitation to
discuss a strategy for mandatory HIA reporting.
State Laws Undermine HAI Reporting
Ina2008studypublishedintheAmerican Journal of Infection Con-
trol, the authors estimated that 10 percent, or about two million
American hospital patients, acquire a clinically significant HAI ev-
ery year.2
These infections result in 100,000 deaths per year, making
HAIs one of the top five causes of death in the United States.HAIs
also cost US hospitals between $28 billion and $45 billionper year
to treat. Reducing the number of HAIs will save lives and reduce
healthcare costs, both of which are imperative, so why aren’t hos-
pitals at least required to report on HAI incidences?
Only state governments can regulate and mandate HAI report-
ing to their state’s department of health and to the National Health
SafetyNetwork(NHSN),theresearchbranchoftheCentersforDis-
easeControlandPrevention(CDC)thatstudiesHAI.6
Currently,16
outof50stategovernmentsdonotrequireHAIreportingatall,and
of those states that do require HAI reporting, many limit the types
of HAI data that hospitals must report. Also certain hospitals are
excluded from reporting HAI data if their hospitals do not perform
the specific procedure that can lead to an HAI.
These omissions and exceptions are reasonable compromises
when hospitals expend manual efforts to gather this data. But from
a research perspective, these omissions limit the quantity and the
completeness of the data, requiring researchers to make assump-
tions about HAI incidence.7
Table 1 on page 55 shows current na-
tional HAI reporting requirements for each state, by HAI type.
What Gets Measured Gets Improved
As shown on Table 1, only 11 states require reporting on all types
of HAI; 23 states require that only certain types of HAIs be report-
ed; and 16 states do not require HAI reporting of any kind. Curi-
ously, the National Health Safety Network did not report on ven-
tilator associated events/ventilator associated pneumonia (VAE/
VAP) types of HAI in their latest, annual progress report, though
Navigating Privacy & Security / e-HIM Best Practices / Standards Strategies / Quality Care
Working Smart a professional practice forum
Journal of AHIMA January 16 / 45
DEFINITIONS:
SSI = Surgical-site infection
CLABSI = Central line-associated bloodstream infection
CAUTI = Associated urinary tract infection
MRSA = Methicillin-resistant Staphylococcus aureus
CDI = Clostridium difficile
VAP = Ventilator-associated pneumonia
VAE = Ventilator-associated events
Common Tools Used by Project Managers
+ Not all hospitals required to report on these infections (i.e., some hospitals do not use urinary catheters so CAUTI would not apply).
++ State mandated. Requires hospitals in the state to report HAI to the NHSN.
Source: Centers for Disease Control and Prevention. “National and State Healthcare Associated Infections: Progress Report (Based on 2013 Data).” January 2015.
www.cdc.gov/HAI/pdfs/progress-report/hai-progress-report.pdf.
State Total NHSN+ CLABSI CAUTI SSI MRSA CDI
Alabama 118 75 Y Y
Alaska 26 10
Arizona 97 56
Arkansas 87 48 Y Y Y Y Y
California 417 350 Y Y Y Y
Colorado 94 52 Y Y
Connecticut 41 30 Y Y Y Y Y
Delaware 13 8 Y Y Y Y Y
Florida 237 191
Georgia 166 102 Y Y Y Y Y
Hawaii 27 15 Y Y Y Y Y
Idaho 47 16
Illinois 207 148 Y Y Y
Indiana 148 104 Y Y Y Y
Iowa 122 50
Kansas 149 49
Kentucky 116 72
Louisiana 172 79
Maine 41 21 Y
Maryland 59 47 Y
Massachusetts 95 69 Y
Michigan 157 97
Minnesota 144 47 Y Y Y Y Y
Mississippi 111 47
Missouri 135 74
Montana 64 14
Nebraska 95 20
Nevada 46 23 Y Y
New Hampshire 29 24 Y Y Y
New Jersey 94 72 Y Y Y Y
New Mexico 48 36 Y Y
New York 251 172 Y Y Y
North Carolina 133 98 Y Y Y Y
North Dakota 48 6
Ohio 203 137 Y Y
Oklahoma 144 53 Y
Oregon 64 49 Y Y Y
Pennsylvania 221 172 Y Y Y Y Y
Rhode Island 14 11 Y Y
South Carolina 81 65 Y Y Y
South Dakota 64 16
Tennessee 154 95 Y Y Y Y Y
Texas 506 281 Y Y
Utah 53 26 Y Y Y Y Y
Vermont 16 7 Y Y
Virginia 109 81 Y
Washington 103 83 Y Y
West Virginia 58 43 Y Y Y Y Y
Wisconsin 144 90
Wyoming 31 21
Hospitals HAI Reporting by State State Mandated Data in Report++
46 / Journal of AHIMA January 16
Navigating Privacy & Security / e-HIM Best Practices / Standards Strategies / Quality Care
Working Smart a professional practice forum
they do list VAE/VAP on their website. VAP infections cause more
deathsthantheothertypesofHAIasillustratedinTable2onpage
56, so HAI reporting inconsistencies exist at the federal level too.
TopreventHAIrequiresthathealthcareprofessionalsfirstunder-
standallthecausesofHAI,whichrequirestheindustrytoestablish
and enforce national HAI reporting guidelines in all 50 states. But,
rather than fight an uphill battle with 50 state legislatures, the most
expedientroutetogethospitalstoreportHAIdatawouldbetohave
CMS require that hospitals provide their HAI data or reduce their
meaningful use program reimbursements if they do not comply.
With 72 percent of hospitals using EHRs to report to CMS today,
the industry already has the means to collect and report HAI data.8
The CDC’s 2013 Progress Report on “National and State Health-
careAssociatedInfections”(fromwhichTable1wasderived)dem-
onstrates the potential impact of collecting all HAI data. Case in
point are central line-associated bloodstream infections (CLABSI).
TheseinfectionsaretheonlytypeofHAItobemandatedbyover50
percent of states and are also the only type of HAI to have been re-
ducedby50percentinlessthan10years.Thisexamplehelpsprove
the maxim that “what gets measured, gets improved.”
Call to Action
More than 72 percent of healthcare providers already use their
EHR systems to report meaningful use clinical, quality, and
public health data to CMS. If CMS would reimburse hospitals
for their HAI data or reduce payment if they do not provide it,
the healthcare industry would have a proven, reliable method
for obtaining the HAI data. Including HAI data with meaningful
use reports takes little effort, and the costs should be more than
offset by CMS payments for hospitals’ HAI data.
Once HAI data collection and reporting are automated, there is
noreasonthatHAIdatacouldnotbecollectedevenmorefrequent-
ly without imposing additional costs on hospitals. Adding EHRs to
the real-time surveillance mechanisms already in place should
greatly improve public health work and the ability of epidemiolo-
gists to monitor infectious diseases and prevent future outbreaks.
With 100,000 lives at stake, surely the idea is worth a discussion. ¢
Notes
	 1.	 Stone, Patricia et al. “CMS Changes in Reimbursement for
HAIs: Setting a Research Agenda.” Medical Care 48, no. 5
(2010): 433–439
	 2.	 Young, Jeremy et al. “Real-time surveillance and decision
support: Optimizing infection control and antimicrobial
choices at the point of care.” American Journal of Infection
Control 36 (2008): S67-74.
	 3.	 Klevens, Monina, et al. “Estimating health care-associat-
ed infections and deaths in U.S. hospitals, 2002.” Public
Health Reports 122, no. 2 (2007): 160-166.
	 4.	 Stone, Patricia. “Economic burden of healthcare-associat-
ed infections: An American perspective.” Expert Review of
Pharmacoeconomics & Outcomes Research 9, no. 5 (2009):
417–422.
	 5.	 Roberts, Rebecca et al. “Costs attributable to healthcare-
acquired infection in hospitalized adults and a comparison
of economic methods.” Medical Care 48, no. 11 (2010): 1026-
1035.
	 6.	 National Healthcare Safety Network. “CMS Resources for
NHSN Users.” October 14, 2015. www.cdc.gov/nhsn/cms/
index.html#ach.
	 7.	 Agency for Healthcare Research and Quality. “Advances in
the Prevention and Control of HAIs.” June 2014. www.im-
paqint.com/sites/default/files/files/advancesinhai.pdf.
	 7.	 Heisey-Grove, Dawn et al. “Hospital Reporting on Mean-
ingful Use Public Health Measures in 2014.” ONC Data
Brief 22 (March 2015). www.healthit.gov/sites/default/
files/databrief22_hospitalreporting.pdf.
John R. Cange (johncange@gmail.com) is president and senior consultant at
Midwest Informatics, LLC.
Table 2: HAI Costs Adapted from NHSN 2013 Progress Report
+ Note that NSHN collects VAE/VAP data, but did not include it in their 2013 report.
Source: Centers for Disease Control and Prevention. “National and State Healthcare Associated Infections: Progress Report (Based on 2013 Data).” January
2015. www.cdc.gov/HAI/pdfs/progress-report/hai-progress-report.pdf.
HAI Infection Type # Infections per Year Cost per Infection # Deaths per Year % Deaths per Infection
Surgical-site infection (SSI) 290,485 $25,546 13,088 5%
Ventilator-associated
pneumonia (VAP) +
250,205 $9,966 35,967 14%
Central line-associated
bloodstream infection
(CLABSI)
248,678 $36,441 30,655 12%
Catheter-associated urinary
tract infection (CAUTI)
561,677 $1,006 8,205 1%

More Related Content

What's hot

Expanding_Access_to_Healthcare_in_Ohio
Expanding_Access_to_Healthcare_in_OhioExpanding_Access_to_Healthcare_in_Ohio
Expanding_Access_to_Healthcare_in_Ohio
Tom Lampman
 
Cap 5. socioeconomic issues in medicine
Cap 5.  socioeconomic issues in medicineCap 5.  socioeconomic issues in medicine
Cap 5. socioeconomic issues in medicine
charly-mau
 
Kaufman_et_al-2015-The_Journal_of_Rural_Health
Kaufman_et_al-2015-The_Journal_of_Rural_HealthKaufman_et_al-2015-The_Journal_of_Rural_Health
Kaufman_et_al-2015-The_Journal_of_Rural_Health
Brystana Kaufman
 
California Competes - CA Wellness Foundation Conference on Health Professions
California Competes - CA Wellness Foundation Conference on Health ProfessionsCalifornia Competes - CA Wellness Foundation Conference on Health Professions
California Competes - CA Wellness Foundation Conference on Health Professions
CalCompetes
 

What's hot (19)

The Meaningful Care Organization: Developing Patient Engagement Strategies
The Meaningful Care Organization: Developing Patient Engagement StrategiesThe Meaningful Care Organization: Developing Patient Engagement Strategies
The Meaningful Care Organization: Developing Patient Engagement Strategies
 
Lancet oncol 2021
Lancet oncol 2021Lancet oncol 2021
Lancet oncol 2021
 
Re-admit Historical using SAS Visual Analytics
Re-admit Historical  using SAS Visual AnalyticsRe-admit Historical  using SAS Visual Analytics
Re-admit Historical using SAS Visual Analytics
 
Cost burdenofchronic pain
Cost burdenofchronic painCost burdenofchronic pain
Cost burdenofchronic pain
 
Adherencia al tarv en am latina y caribe
Adherencia al tarv en am latina y caribeAdherencia al tarv en am latina y caribe
Adherencia al tarv en am latina y caribe
 
The Economics of Quality in Healthcare
The Economics of Quality in HealthcareThe Economics of Quality in Healthcare
The Economics of Quality in Healthcare
 
Determinants of first line antiretroviral treatment failure in public hospita...
Determinants of first line antiretroviral treatment failure in public hospita...Determinants of first line antiretroviral treatment failure in public hospita...
Determinants of first line antiretroviral treatment failure in public hospita...
 
Depresion y vih rep2014
Depresion y vih rep2014Depresion y vih rep2014
Depresion y vih rep2014
 
Expanding_Access_to_Healthcare_in_Ohio
Expanding_Access_to_Healthcare_in_OhioExpanding_Access_to_Healthcare_in_Ohio
Expanding_Access_to_Healthcare_in_Ohio
 
Cap 5. socioeconomic issues in medicine
Cap 5.  socioeconomic issues in medicineCap 5.  socioeconomic issues in medicine
Cap 5. socioeconomic issues in medicine
 
Kaufman_et_al-2015-The_Journal_of_Rural_Health
Kaufman_et_al-2015-The_Journal_of_Rural_HealthKaufman_et_al-2015-The_Journal_of_Rural_Health
Kaufman_et_al-2015-The_Journal_of_Rural_Health
 
Financial Disclosures in Academic Publications and the Sunshine Act: A Concor...
Financial Disclosures in Academic Publications and the Sunshine Act: A Concor...Financial Disclosures in Academic Publications and the Sunshine Act: A Concor...
Financial Disclosures in Academic Publications and the Sunshine Act: A Concor...
 
California Competes - CA Wellness Foundation Conference on Health Professions
California Competes - CA Wellness Foundation Conference on Health ProfessionsCalifornia Competes - CA Wellness Foundation Conference on Health Professions
California Competes - CA Wellness Foundation Conference on Health Professions
 
HiHealth.io
HiHealth.ioHiHealth.io
HiHealth.io
 
MEDICARE HEALTHCARE CHARGE DISPARITY ANALYSIS
MEDICARE HEALTHCARE CHARGE DISPARITY ANALYSISMEDICARE HEALTHCARE CHARGE DISPARITY ANALYSIS
MEDICARE HEALTHCARE CHARGE DISPARITY ANALYSIS
 
Ojchd.000523
Ojchd.000523Ojchd.000523
Ojchd.000523
 
Metaanalisis VIH y Depresión
Metaanalisis  VIH y Depresión Metaanalisis  VIH y Depresión
Metaanalisis VIH y Depresión
 
2014 Report: Medicines in Development for HIV/AIDS
2014 Report: Medicines in Development for HIV/AIDS2014 Report: Medicines in Development for HIV/AIDS
2014 Report: Medicines in Development for HIV/AIDS
 
Dissertation
DissertationDissertation
Dissertation
 

Viewers also liked

Héritage de Charles Trenet - L'erreur d'un juge
Héritage de Charles Trenet - L'erreur d'un juge Héritage de Charles Trenet - L'erreur d'un juge
Héritage de Charles Trenet - L'erreur d'un juge
Maurice Khardine
 
Atreyu term 3
Atreyu term 3Atreyu term 3
Atreyu term 3
figjam_31
 
2016 Michael Wilson Resume
2016 Michael Wilson Resume2016 Michael Wilson Resume
2016 Michael Wilson Resume
Michael Wilson
 

Viewers also liked (10)

Siller 3.0
Siller 3.0Siller 3.0
Siller 3.0
 
Ashley Term 3
Ashley Term 3Ashley Term 3
Ashley Term 3
 
(771474185) mapa curricular-informática
(771474185) mapa curricular-informática(771474185) mapa curricular-informática
(771474185) mapa curricular-informática
 
Héritage de Charles Trenet - L'erreur d'un juge
Héritage de Charles Trenet - L'erreur d'un juge Héritage de Charles Trenet - L'erreur d'un juge
Héritage de Charles Trenet - L'erreur d'un juge
 
Atreyu term 3
Atreyu term 3Atreyu term 3
Atreyu term 3
 
certificate 2
certificate 2certificate 2
certificate 2
 
Emily M Term 3
Emily M Term 3Emily M Term 3
Emily M Term 3
 
130320 dl
130320 dl130320 dl
130320 dl
 
bernard arthur
bernard arthurbernard arthur
bernard arthur
 
2016 Michael Wilson Resume
2016 Michael Wilson Resume2016 Michael Wilson Resume
2016 Michael Wilson Resume
 

Similar to WS_Quality

The New Focus on Quality and OutcomesIntroductionIn 1999, the .docx
The New Focus on Quality and OutcomesIntroductionIn 1999, the .docxThe New Focus on Quality and OutcomesIntroductionIn 1999, the .docx
The New Focus on Quality and OutcomesIntroductionIn 1999, the .docx
oreo10
 
CHAPter3ConneCting tHe strAtegiC Dots Does Hit mAt.docx
CHAPter3ConneCting tHe strAtegiC Dots  Does Hit mAt.docxCHAPter3ConneCting tHe strAtegiC Dots  Does Hit mAt.docx
CHAPter3ConneCting tHe strAtegiC Dots Does Hit mAt.docx
tiffanyd4
 
CHAPter3ConneCting tHe strAtegiC Dots Does Hit mAt.docx
CHAPter3ConneCting tHe strAtegiC Dots  Does Hit mAt.docxCHAPter3ConneCting tHe strAtegiC Dots  Does Hit mAt.docx
CHAPter3ConneCting tHe strAtegiC Dots Does Hit mAt.docx
mccormicknadine86
 
Death By Medicine
Death By MedicineDeath By Medicine
Death By Medicine
Ray Gebauer
 
Downloadedfromhttpjournals.lww.comjphm
Downloadedfromhttpjournals.lww.comjphmDownloadedfromhttpjournals.lww.comjphm
Downloadedfromhttpjournals.lww.comjphm
DustiBuckner14
 
Ohio SEPs State Fact Sheet_01.14.14
Ohio SEPs State Fact Sheet_01.14.14Ohio SEPs State Fact Sheet_01.14.14
Ohio SEPs State Fact Sheet_01.14.14
Mary Beth Levin
 
Please follow instructions carefully. Thank you so kindly. Ass.docx
Please follow instructions carefully. Thank you so kindly. Ass.docxPlease follow instructions carefully. Thank you so kindly. Ass.docx
Please follow instructions carefully. Thank you so kindly. Ass.docx
mattjtoni51554
 

Similar to WS_Quality (20)

The New Focus on Quality and OutcomesIntroductionIn 1999, the .docx
The New Focus on Quality and OutcomesIntroductionIn 1999, the .docxThe New Focus on Quality and OutcomesIntroductionIn 1999, the .docx
The New Focus on Quality and OutcomesIntroductionIn 1999, the .docx
 
MEDICAL ETHICS AND CONFLICT OF INTEREST IN SCIENTIFIC MEDICINE
MEDICAL ETHICS AND CONFLICT OF INTEREST IN SCIENTIFIC MEDICINEMEDICAL ETHICS AND CONFLICT OF INTEREST IN SCIENTIFIC MEDICINE
MEDICAL ETHICS AND CONFLICT OF INTEREST IN SCIENTIFIC MEDICINE
 
hp2020_BDBS_and_HAI_progress_review_presentation (1).pptx
hp2020_BDBS_and_HAI_progress_review_presentation (1).pptxhp2020_BDBS_and_HAI_progress_review_presentation (1).pptx
hp2020_BDBS_and_HAI_progress_review_presentation (1).pptx
 
Reducing Hospital Readmissions and Length of Stay in Advanced Illness Patients
Reducing Hospital Readmissions and Length of Stay in Advanced Illness PatientsReducing Hospital Readmissions and Length of Stay in Advanced Illness Patients
Reducing Hospital Readmissions and Length of Stay in Advanced Illness Patients
 
Does Providing Recommended Treatments Equal Low Mortality Rates
Does Providing Recommended Treatments Equal Low Mortality RatesDoes Providing Recommended Treatments Equal Low Mortality Rates
Does Providing Recommended Treatments Equal Low Mortality Rates
 
Clinical Preventive Services - JAMA 4-28-15
Clinical Preventive Services - JAMA 4-28-15Clinical Preventive Services - JAMA 4-28-15
Clinical Preventive Services - JAMA 4-28-15
 
Health Care by the Numbers
Health Care by the NumbersHealth Care by the Numbers
Health Care by the Numbers
 
CHAPter3ConneCting tHe strAtegiC Dots Does Hit mAt.docx
CHAPter3ConneCting tHe strAtegiC Dots  Does Hit mAt.docxCHAPter3ConneCting tHe strAtegiC Dots  Does Hit mAt.docx
CHAPter3ConneCting tHe strAtegiC Dots Does Hit mAt.docx
 
CHAPter3ConneCting tHe strAtegiC Dots Does Hit mAt.docx
CHAPter3ConneCting tHe strAtegiC Dots  Does Hit mAt.docxCHAPter3ConneCting tHe strAtegiC Dots  Does Hit mAt.docx
CHAPter3ConneCting tHe strAtegiC Dots Does Hit mAt.docx
 
Death By Medicine
Death By MedicineDeath By Medicine
Death By Medicine
 
Downloadedfromhttpjournals.lww.comjphm
Downloadedfromhttpjournals.lww.comjphmDownloadedfromhttpjournals.lww.comjphm
Downloadedfromhttpjournals.lww.comjphm
 
Middleton.Cgu2005v6
Middleton.Cgu2005v6Middleton.Cgu2005v6
Middleton.Cgu2005v6
 
Group 3 week 10 presentation
Group 3 week 10 presentationGroup 3 week 10 presentation
Group 3 week 10 presentation
 
Ohio SEPs State Fact Sheet_01.14.14
Ohio SEPs State Fact Sheet_01.14.14Ohio SEPs State Fact Sheet_01.14.14
Ohio SEPs State Fact Sheet_01.14.14
 
The future of healthcare and big data
The future of healthcare and big dataThe future of healthcare and big data
The future of healthcare and big data
 
Cross the Finish Line First
Cross the Finish Line FirstCross the Finish Line First
Cross the Finish Line First
 
Please follow instructions carefully. Thank you so kindly. Ass.docx
Please follow instructions carefully. Thank you so kindly. Ass.docxPlease follow instructions carefully. Thank you so kindly. Ass.docx
Please follow instructions carefully. Thank you so kindly. Ass.docx
 
Population health management real time state-of-health analysis
Population health management real time state-of-health analysisPopulation health management real time state-of-health analysis
Population health management real time state-of-health analysis
 
Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture
Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine LecturePeter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture
Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture
 
Reducing Readmissions and Length of Stay
Reducing Readmissions and Length of StayReducing Readmissions and Length of Stay
Reducing Readmissions and Length of Stay
 

WS_Quality

  • 1. 44 / Journal of AHIMA January 16 O Preventing Hospital Acquired Infections Starts with Data Collection By John R. Cange, MSHI ONE OUT OF 10 US hospital patients contract an infection dur- ing their hospital stay, resulting in thousands of unnecessary deaths and billions of dollars in unnecessary costs. Almost all hospital acquired infections (HAI) are preventable, which is why the Centers for Medicare and Medicaid Services (CMS) no longer reimburse hospitals for the costs to treat HAI.1 To prevent a problem, however, requires that you understand the potential causes of the problem—and this understanding requires data. A complete understanding requires a complete dataset. In the case of HAI, the ideal dataset would contain data concerning every type of HAI from every hospital in every state. Only some states require HAI data collection on all of the major types of HAI. Half of states report on some types of HAIs and not others, while many hospitals do not report on HAIs of any type. In the near term, there is little chance that all 50 states will start requiring HAI reporting by imposing new state regulations, but there is hope. Hospitals could report on HAIs with little effort or additional cost by including HAI data with the “meaningful use” EHR Incentive Program data they already provide to CMS through their electronic health record (EHR) systems. EHRs are nearly ubiquitous in US hospitals today. Consequent- ly, some have argued that CMS should mandate HAI reporting of alltypesbyreimbursinghospitalsfortheirHAIdataaspartoftheir meaningful use payments or reducing their HAI reimbursement if the hospital does not comply. This strategy has been proven to be very effective with CMS’ meaningful use reporting. Ultimately, this article serves as a call to action to CMS and an invitation to discuss a strategy for mandatory HIA reporting. State Laws Undermine HAI Reporting Ina2008studypublishedintheAmerican Journal of Infection Con- trol, the authors estimated that 10 percent, or about two million American hospital patients, acquire a clinically significant HAI ev- ery year.2 These infections result in 100,000 deaths per year, making HAIs one of the top five causes of death in the United States.HAIs also cost US hospitals between $28 billion and $45 billionper year to treat. Reducing the number of HAIs will save lives and reduce healthcare costs, both of which are imperative, so why aren’t hos- pitals at least required to report on HAI incidences? Only state governments can regulate and mandate HAI report- ing to their state’s department of health and to the National Health SafetyNetwork(NHSN),theresearchbranchoftheCentersforDis- easeControlandPrevention(CDC)thatstudiesHAI.6 Currently,16 outof50stategovernmentsdonotrequireHAIreportingatall,and of those states that do require HAI reporting, many limit the types of HAI data that hospitals must report. Also certain hospitals are excluded from reporting HAI data if their hospitals do not perform the specific procedure that can lead to an HAI. These omissions and exceptions are reasonable compromises when hospitals expend manual efforts to gather this data. But from a research perspective, these omissions limit the quantity and the completeness of the data, requiring researchers to make assump- tions about HAI incidence.7 Table 1 on page 55 shows current na- tional HAI reporting requirements for each state, by HAI type. What Gets Measured Gets Improved As shown on Table 1, only 11 states require reporting on all types of HAI; 23 states require that only certain types of HAIs be report- ed; and 16 states do not require HAI reporting of any kind. Curi- ously, the National Health Safety Network did not report on ven- tilator associated events/ventilator associated pneumonia (VAE/ VAP) types of HAI in their latest, annual progress report, though Navigating Privacy & Security / e-HIM Best Practices / Standards Strategies / Quality Care Working Smart a professional practice forum
  • 2. Journal of AHIMA January 16 / 45 DEFINITIONS: SSI = Surgical-site infection CLABSI = Central line-associated bloodstream infection CAUTI = Associated urinary tract infection MRSA = Methicillin-resistant Staphylococcus aureus CDI = Clostridium difficile VAP = Ventilator-associated pneumonia VAE = Ventilator-associated events Common Tools Used by Project Managers + Not all hospitals required to report on these infections (i.e., some hospitals do not use urinary catheters so CAUTI would not apply). ++ State mandated. Requires hospitals in the state to report HAI to the NHSN. Source: Centers for Disease Control and Prevention. “National and State Healthcare Associated Infections: Progress Report (Based on 2013 Data).” January 2015. www.cdc.gov/HAI/pdfs/progress-report/hai-progress-report.pdf. State Total NHSN+ CLABSI CAUTI SSI MRSA CDI Alabama 118 75 Y Y Alaska 26 10 Arizona 97 56 Arkansas 87 48 Y Y Y Y Y California 417 350 Y Y Y Y Colorado 94 52 Y Y Connecticut 41 30 Y Y Y Y Y Delaware 13 8 Y Y Y Y Y Florida 237 191 Georgia 166 102 Y Y Y Y Y Hawaii 27 15 Y Y Y Y Y Idaho 47 16 Illinois 207 148 Y Y Y Indiana 148 104 Y Y Y Y Iowa 122 50 Kansas 149 49 Kentucky 116 72 Louisiana 172 79 Maine 41 21 Y Maryland 59 47 Y Massachusetts 95 69 Y Michigan 157 97 Minnesota 144 47 Y Y Y Y Y Mississippi 111 47 Missouri 135 74 Montana 64 14 Nebraska 95 20 Nevada 46 23 Y Y New Hampshire 29 24 Y Y Y New Jersey 94 72 Y Y Y Y New Mexico 48 36 Y Y New York 251 172 Y Y Y North Carolina 133 98 Y Y Y Y North Dakota 48 6 Ohio 203 137 Y Y Oklahoma 144 53 Y Oregon 64 49 Y Y Y Pennsylvania 221 172 Y Y Y Y Y Rhode Island 14 11 Y Y South Carolina 81 65 Y Y Y South Dakota 64 16 Tennessee 154 95 Y Y Y Y Y Texas 506 281 Y Y Utah 53 26 Y Y Y Y Y Vermont 16 7 Y Y Virginia 109 81 Y Washington 103 83 Y Y West Virginia 58 43 Y Y Y Y Y Wisconsin 144 90 Wyoming 31 21 Hospitals HAI Reporting by State State Mandated Data in Report++
  • 3. 46 / Journal of AHIMA January 16 Navigating Privacy & Security / e-HIM Best Practices / Standards Strategies / Quality Care Working Smart a professional practice forum they do list VAE/VAP on their website. VAP infections cause more deathsthantheothertypesofHAIasillustratedinTable2onpage 56, so HAI reporting inconsistencies exist at the federal level too. TopreventHAIrequiresthathealthcareprofessionalsfirstunder- standallthecausesofHAI,whichrequirestheindustrytoestablish and enforce national HAI reporting guidelines in all 50 states. But, rather than fight an uphill battle with 50 state legislatures, the most expedientroutetogethospitalstoreportHAIdatawouldbetohave CMS require that hospitals provide their HAI data or reduce their meaningful use program reimbursements if they do not comply. With 72 percent of hospitals using EHRs to report to CMS today, the industry already has the means to collect and report HAI data.8 The CDC’s 2013 Progress Report on “National and State Health- careAssociatedInfections”(fromwhichTable1wasderived)dem- onstrates the potential impact of collecting all HAI data. Case in point are central line-associated bloodstream infections (CLABSI). TheseinfectionsaretheonlytypeofHAItobemandatedbyover50 percent of states and are also the only type of HAI to have been re- ducedby50percentinlessthan10years.Thisexamplehelpsprove the maxim that “what gets measured, gets improved.” Call to Action More than 72 percent of healthcare providers already use their EHR systems to report meaningful use clinical, quality, and public health data to CMS. If CMS would reimburse hospitals for their HAI data or reduce payment if they do not provide it, the healthcare industry would have a proven, reliable method for obtaining the HAI data. Including HAI data with meaningful use reports takes little effort, and the costs should be more than offset by CMS payments for hospitals’ HAI data. Once HAI data collection and reporting are automated, there is noreasonthatHAIdatacouldnotbecollectedevenmorefrequent- ly without imposing additional costs on hospitals. Adding EHRs to the real-time surveillance mechanisms already in place should greatly improve public health work and the ability of epidemiolo- gists to monitor infectious diseases and prevent future outbreaks. With 100,000 lives at stake, surely the idea is worth a discussion. ¢ Notes 1. Stone, Patricia et al. “CMS Changes in Reimbursement for HAIs: Setting a Research Agenda.” Medical Care 48, no. 5 (2010): 433–439 2. Young, Jeremy et al. “Real-time surveillance and decision support: Optimizing infection control and antimicrobial choices at the point of care.” American Journal of Infection Control 36 (2008): S67-74. 3. Klevens, Monina, et al. “Estimating health care-associat- ed infections and deaths in U.S. hospitals, 2002.” Public Health Reports 122, no. 2 (2007): 160-166. 4. Stone, Patricia. “Economic burden of healthcare-associat- ed infections: An American perspective.” Expert Review of Pharmacoeconomics & Outcomes Research 9, no. 5 (2009): 417–422. 5. Roberts, Rebecca et al. “Costs attributable to healthcare- acquired infection in hospitalized adults and a comparison of economic methods.” Medical Care 48, no. 11 (2010): 1026- 1035. 6. National Healthcare Safety Network. “CMS Resources for NHSN Users.” October 14, 2015. www.cdc.gov/nhsn/cms/ index.html#ach. 7. Agency for Healthcare Research and Quality. “Advances in the Prevention and Control of HAIs.” June 2014. www.im- paqint.com/sites/default/files/files/advancesinhai.pdf. 7. Heisey-Grove, Dawn et al. “Hospital Reporting on Mean- ingful Use Public Health Measures in 2014.” ONC Data Brief 22 (March 2015). www.healthit.gov/sites/default/ files/databrief22_hospitalreporting.pdf. John R. Cange (johncange@gmail.com) is president and senior consultant at Midwest Informatics, LLC. Table 2: HAI Costs Adapted from NHSN 2013 Progress Report + Note that NSHN collects VAE/VAP data, but did not include it in their 2013 report. Source: Centers for Disease Control and Prevention. “National and State Healthcare Associated Infections: Progress Report (Based on 2013 Data).” January 2015. www.cdc.gov/HAI/pdfs/progress-report/hai-progress-report.pdf. HAI Infection Type # Infections per Year Cost per Infection # Deaths per Year % Deaths per Infection Surgical-site infection (SSI) 290,485 $25,546 13,088 5% Ventilator-associated pneumonia (VAP) + 250,205 $9,966 35,967 14% Central line-associated bloodstream infection (CLABSI) 248,678 $36,441 30,655 12% Catheter-associated urinary tract infection (CAUTI) 561,677 $1,006 8,205 1%